2. UroToday Home
  3. Conferences

GU Cancers Symposium 2014

gucancerssympalt Genitourinary Cancers Symposium 2014

January 30 - February 1, 2014

San Francisco Marriott Marquis
San Francisco, CA USA

Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer - Abstract

Galectin-1, a β-galactoside-binding lectin, is involved in many physiologic and pathologic processes, including cell adhesion, differentiation, angiogenesis, and tumor progression.

GU Cancers Symposium 2014 - Axitinib: Common questions related to real-world use of a new treatment option in advanced renal cell carcinoma - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Diane Lorraine Borst, Lillian Shahied Arruda, Elizabeth A. MacLean, Yazdi K. Pithavala, James E. Morgado, and Nikhil Sharma at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Heterogeneity of intermediate prognosis patients with metastatic renal cell cancer treated with sunitinib - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Avishay Sella, M. Dror Michaelson, Ewa M. Matczak, Ronit Simantov, Mariajose Lechuga, Xun Lin, and Robert A. Figlin at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Impact of angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Rana R. McKay, Gustavo Enrique Rodriguez, Xun Lin, Ronit Simantov, and Toni K. Choueiri at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Correlation between patient-reported fatigue and hemoglobin levels in metastatic renal cell carcinoma patients receiving sunitinib - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Mellar P. Davis, Ewa M. Matczak, Connie Chen, Beata Korytowsky, Helen Bhattacharyya, Xun Lin, and Brian I. Rini at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Growth kinetics and outcomes of clinical T1b renal masses under active surveillance - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Reza Mehrazin, Marc C. Smaldone, Alexander Kutikov, Jeffrey J. Tomaszewski, Tianyu Li, Rosalia Viterbo, Richard E. Greenberg, David Y. T. Chen, and Robert G. Uzzo at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Reza Mehrazin, Robert G. Uzzo, Alexander Kutikov, Jeffrey J. Tomaszewski, Serge Ginzburg, Karen J. Ruth, Essel Al-Saleem, David Y. T. Chen, Rosalia Viterbo, Richard E. Greenberg, Marc C. Smaldone, and Tahseen I. Al-Saleem at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Open-label, phase II RAPTOR study of everolimus for papillary mRCC: Efficacy in type 1 and type 2 histology - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Bernard J. Escudier, Sergio Bracarda, José Pablo Maroto Rey, Cezary Szczylik, Paul D. Nathan, Sylvie Negrier, Agnese Cattaneo, Claudia Weiss, Camillo Porta, and Viktor Gruenwald at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - In vitro and in vivo effects of the mTOR inhibitors everolimus and temsirolimus - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by David Chen, Michael Terence O'Reilly, and Paul M.J. McSheehy at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Everolimus as second-line therapy for metastatic renal cell carcinoma after one previous VEGF-targeted therapy: Final results of the noninterventional change study - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Peter J. Goebell, Ulrich Kube, Michael Staehler, Christian Doehn, Thomas Steiner, Manfred Kindler, Edwin Herrmann, Jan Janssen, Steffen Weikert, Michael Thomas Scheffler, Joerg Schmitz, Friedrich Overkamp, Gernot Guderian, Michael Albrecht, and Lothar Bergmann at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Biomarker analysis from a phase III trial (GOLD) of dovitinib vs sorafenibin patients with metastatic renal cell carcinoma after one prior VEGF pathway-targeted therapy and one prior mTOR inhibitor therapy - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Bernard J. Escudier, Camillo Porta, Matthew Squires, Cezary Szczylik, Christian K. Kollmannsberger, Bohuslav Melichar, Sun Young Rha, Emilio Esteban, Georg A. Bjarnason, Nicholas J. Vogelzang, Cora N. Sternberg, Michael Shi, Mathab Marker, and Robert John Motzer at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Second-line prescribing preferences of U.S.-based medical oncologists following first-line TKI in patients with metastatic clear cell renal cell carcinoma - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Charles J. Ryan, Mark R. Green, Susan L. Britton, Arden Buettner, Maria Lankford, Douglas Neely at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Jonathan E. Rosenberg, Jaegil Kim, Andrew Cherniack, Carrie Sougnez, Matthew Meyerson, Gad Getz, John N. Weinstein, Seth P. Lerner, David J. Kwiatkowski, and The Cancer Genome Atlas Research Network Bladder Cancer Project at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Kristian D. Stensland, Russell McBride, Juan P. Wisnivesky, Asma Latif, Ryan Hendricks, Nitin Roper, Paolo Boffetta, Simon J Hall, William K. Oh, and Matt D. Galsky at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Consideration of height-based rather than weight-based dosing as a more appropriate method of treating with radium-223 - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Thomas Andrew Longo, Matthew McDonald, Samuel H. Mehr, and Luke T. Nordquist at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Clinical and biologic factors for immune response to sipuleucel-T for metastatic castrate-resistant prostate cancer - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Mehmet Faith Hepgur, Tanya B. Dorff, Lucy Brining, Jie Cai, Jacek K. Pinski, Mary Reed, Michael Luther, Betty Chan, David I. Quinn at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Increase in bone scan index during abiraterone treatment in relation to reduced survival in mCRPC patients - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Mariana Reza, Anders Bjartell, Mattias Ohlsson, Lars Edenbrandt, and Elin Tragardh at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7 - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Matthew R. Cooperberg, Stephen J. Freedland, Thorsten Schlomm, Julia E. Reid, Steven Stone, and Michael K. Brawer at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - The effect of cell cycle progression score on treatment decisions in prostate cancer: Results of an ongoing registry trial - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Ashok J. Kar, Mark Creamer Scholz, Jeffrey E. Fegan, E. David Crawford, Peter T. Scardino, Rajesh R. Kaldate, and Michael K. Brawer at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

GU Cancers Symposium 2014 - Cell cycle progression score to predict metastatic progression of clear cell renal cell carcinoma after resection - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Eric J. Askeland, Vincent A. Chehval, Ryan W. Askeland, Zaina Sangale, Placede Gangnang Fosso, Nafei Xu, Saradha Rajamani, Steven Stone, and James A. Brown at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

Page 1 of 6